Dr. Adrian Bot, a renowned biopharmaceutical founder and scientist, has joined Immuthera’s Board of Directors to strengthen its pipeline development and commercialization efforts. Immuthera, operating ...

Dr. Adrian Bot joins Immuthera to support the company with his unique experience in commercialization of groundbreaking cell therapies Dr. Adrian Bot, a renowned biopharmaceutical founder and ...

The rise of artificial intelligence has produced serial writers to science and medical journals, most likely using chatbots to boost the number of citations they’ve published. By Gina Kolata Letters ...

The grassroots group, partnered with Louisville Urban League, signs letter of intent to buy NIA Center. They must raise $25K down payment by next week. ‘Not Constitutional’: Trump Threatens Blue Slip ...